Kathryn Dunne
0009-0007-7259-744X
2 papers found
Refreshing results…
Comparison of circulating tumor DNA assays for Molecular Residual Disease detection in early-stage triple negative breast cancer
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Missing publications? Search for publications with a matching author name.